BOULDER, Colo.—Gilead Sciences Inc., a biopharmaceutical firm known for its HIV therapies, is closing its offices in Boulder and Westminster and laying off at least 66 people by year’s end.
Gilead spokesman Nathan Kaiser said Wednesday the decision to close the offices was prompted by the company’s $1.4 billion acquisition of Palo Alto, Calif.-based CV Therapeutics earlier this year.
About half the Colorado employees were offered the opportunity to relocate to California. The Foster City, Calif.-based Gilead has a total of 139 employees in Boulder and Westminster.
Gilead’s announcement follows one by OSI Pharmaceutical Inc. that it was closing some U.S. offices, including its Boulder facility, and moving those positions to New York.
———
Information from: Daily Camera,
